• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ChREBP在肝脏和胰岛中的适应性和适应不良作用。

Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets.

作者信息

Katz Liora S, Baumel-Alterzon Sharon, Scott Donald K, Herman Mark A

机构信息

Icahn School of Medicine at Mount Sinai, Obesity, Diabetes and Metabolism Institute, New York, New York, USA.

Icahn School of Medicine at Mount Sinai, Obesity, Diabetes and Metabolism Institute, New York, New York, USA.

出版信息

J Biol Chem. 2021 Jan-Jun;296:100623. doi: 10.1016/j.jbc.2021.100623. Epub 2021 Apr 2.

DOI:10.1016/j.jbc.2021.100623
PMID:33812993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8102921/
Abstract

Excessive sugar consumption is a contributor to the worldwide epidemic of cardiometabolic disease. Understanding mechanisms by which sugar is sensed and regulates metabolic processes may provide new opportunities to prevent and treat these epidemics. Carbohydrate Responsive-Element Binding Protein (ChREBP) is a sugar-sensing transcription factor that mediates genomic responses to changes in carbohydrate abundance in key metabolic tissues. Carbohydrate metabolites activate the canonical form of ChREBP, ChREBP-alpha, which stimulates production of a potent, constitutively active ChREBP isoform called ChREBP-beta. Carbohydrate metabolites and other metabolic signals may also regulate ChREBP activity via posttranslational modifications including phosphorylation, acetylation, and O-GlcNAcylation that can affect ChREBP's cellular localization, stability, binding to cofactors, and transcriptional activity. In this review, we discuss mechanisms regulating ChREBP activity and highlight phenotypes and controversies in ChREBP gain- and loss-of-function genetic rodent models focused on the liver and pancreatic islets.

摘要

过量摄入糖分是导致全球心血管代谢疾病流行的一个因素。了解糖分被感知以及调节代谢过程的机制,可能为预防和治疗这些流行病提供新的机会。碳水化合物反应元件结合蛋白(ChREBP)是一种糖感应转录因子,它介导关键代谢组织中对碳水化合物丰度变化的基因组反应。碳水化合物代谢产物激活ChREBP的经典形式ChREBP-α,后者刺激产生一种强效的、组成型活性的ChREBP异构体,称为ChREBP-β。碳水化合物代谢产物和其他代谢信号也可能通过翻译后修饰(包括磷酸化、乙酰化和O-连接的N-乙酰葡糖胺化)来调节ChREBP的活性,这些修饰会影响ChREBP的细胞定位、稳定性、与辅因子的结合以及转录活性。在这篇综述中,我们讨论调节ChREBP活性的机制,并重点介绍聚焦于肝脏和胰岛的ChREBP功能获得和功能丧失基因啮齿动物模型中的表型及争议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a3/8102921/cad9deb432bf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a3/8102921/bd411475c386/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a3/8102921/68fdab04caea/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a3/8102921/cad9deb432bf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a3/8102921/bd411475c386/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a3/8102921/68fdab04caea/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a3/8102921/cad9deb432bf/gr3.jpg

相似文献

1
Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets.ChREBP在肝脏和胰岛中的适应性和适应不良作用。
J Biol Chem. 2021 Jan-Jun;296:100623. doi: 10.1016/j.jbc.2021.100623. Epub 2021 Apr 2.
2
Recent progress on the role of ChREBP in glucose and lipid metabolism.ChREBP 在糖脂代谢中的作用的最新进展。
Endocr J. 2013;60(5):543-55. doi: 10.1507/endocrj.ej13-0121. Epub 2013 Apr 19.
3
Sweet Sixteenth for ChREBP: Established Roles and Future Goals.ChREBP 的第十六个年头:既定角色和未来目标。
Cell Metab. 2017 Aug 1;26(2):324-341. doi: 10.1016/j.cmet.2017.07.004.
4
Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop.胰岛 ChREBP-β 在糖尿病中增加,并通过负反馈环控制 ChREBP-α 和葡萄糖诱导的基因表达。
Mol Metab. 2016 Sep 30;5(12):1208-1215. doi: 10.1016/j.molmet.2016.09.010. eCollection 2016 Dec.
5
The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.碳水化合物反应元件结合蛋白在碳水化合物摄入与疾病关系中的作用。
Int J Mol Sci. 2021 Nov 8;22(21):12058. doi: 10.3390/ijms222112058.
6
Tissue-specific response of carbohydrate-responsive element binding protein (ChREBP) to mammalian hibernation in 13-lined ground squirrels.13条纹地松鼠体内碳水化合物反应元件结合蛋白(ChREBP)对哺乳动物冬眠的组织特异性反应。
Cryobiology. 2016 Oct;73(2):103-11. doi: 10.1016/j.cryobiol.2016.09.002. Epub 2016 Sep 8.
7
Importin-alpha protein binding to a nuclear localization signal of carbohydrate response element-binding protein (ChREBP).Importin-alpha 蛋白与碳水化合物反应元件结合蛋白 (ChREBP) 的核定位信号结合。
J Biol Chem. 2011 Aug 12;286(32):28119-27. doi: 10.1074/jbc.M111.237016. Epub 2011 Jun 10.
8
The Protective Role of the Carbohydrate Response Element Binding Protein in the Liver: The Metabolite Perspective.糖反应元件结合蛋白在肝脏中的保护作用:代谢物视角。
Front Endocrinol (Lausanne). 2020 Nov 17;11:594041. doi: 10.3389/fendo.2020.594041. eCollection 2020.
9
Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.近期关于 ChREBP 在肠道果糖吸收和代谢中作用的新见解。
BMB Rep. 2018 Sep;51(9):429-436. doi: 10.5483/BMBRep.2018.51.9.197.
10
ChREBP Regulates Itself and Metabolic Genes Implicated in Lipid Accumulation in β-Cell Line.ChREBP调节其自身以及与β细胞系脂质积累相关的代谢基因。
PLoS One. 2016 Jan 25;11(1):e0147411. doi: 10.1371/journal.pone.0147411. eCollection 2016.

引用本文的文献

1
Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value.代谢功能障碍相关脂肪性肝病中的肠道微生物群与代谢组学:相互作用、机制及治疗价值
Front Cell Infect Microbiol. 2025 Jul 23;15:1635638. doi: 10.3389/fcimb.2025.1635638. eCollection 2025.
2
The Role of Extracellular Vesicles in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Liver Diseases.细胞外囊泡在代谢功能障碍相关脂肪性肝病及其他肝脏疾病发病机制中的作用
Int J Mol Sci. 2025 May 23;26(11):5033. doi: 10.3390/ijms26115033.
3
The sphingosine-1-phosphate receptor 2 S1PR2 mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia.

本文引用的文献

1
Metabolic drivers of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的代谢驱动因素。
Mol Metab. 2021 Aug;50:101143. doi: 10.1016/j.molmet.2020.101143. Epub 2020 Dec 17.
2
Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的肝脏胰岛素抵抗并非选择性通路异常。
Diabetes Care. 2021 Feb;44(2):489-498. doi: 10.2337/dc20-1644. Epub 2020 Dec 8.
3
Nrf2: The Master and Captain of Beta Cell Fate.Nrf2:β 细胞命运的主人和船长。
鞘氨醇-1-磷酸受体2(S1PR2)介导慢性糖皮质激素暴露诱导的肝脂肪变性和高甘油三酯血症。
J Biol Chem. 2025 Jun 7;301(7):110353. doi: 10.1016/j.jbc.2025.110353.
4
Ethanol induction of FGF21 in the liver is dependent on histone acetylation and ligand activation of ChREBP by glycerol-3-phosphate.乙醇诱导肝脏中FGF21的产生依赖于组蛋白乙酰化以及甘油-3-磷酸对ChREBP的配体激活作用。
Proc Natl Acad Sci U S A. 2025 Jun 3;122(22):e2505263122. doi: 10.1073/pnas.2505263122. Epub 2025 May 29.
5
miR-1225-3p regulates fibrosis in mesangial cells via SMURF2-mediated ubiquitination of ChREBP in diabetic kidney disease.在糖尿病肾病中,miR-1225-3p通过SMURF2介导的ChREBP泛素化调节系膜细胞纤维化。
Ren Fail. 2025 Dec;47(1):2484632. doi: 10.1080/0886022X.2025.2484632. Epub 2025 Apr 11.
6
Hepatic Deletion of Carbohydrate Response Element Binding Protein Impairs Hepatocarcinogenesis in a High-Fat Diet-Induced Mouse Model.在高脂肪饮食诱导的小鼠模型中,肝脏中碳水化合物反应元件结合蛋白的缺失会损害肝癌发生。
Int J Mol Sci. 2025 Mar 3;26(5):2246. doi: 10.3390/ijms26052246.
7
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity.调节性ChREBP/14-3-3复合物的分子胶可保护β细胞免受糖脂毒性。
Nat Commun. 2025 Mar 2;16(1):2110. doi: 10.1038/s41467-025-57241-7.
8
Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in Citrin Deficiency.在柠檬酸缺乏症中,3-磷酸甘油激活碳水化合物反应元件结合蛋白(ChREBP)、成纤维细胞生长因子21(FGF21)转录及脂肪生成。
bioRxiv. 2024 Dec 27:2024.12.27.630525. doi: 10.1101/2024.12.27.630525.
9
Liver proteomics identifies a disconnect between proteins associated with de novo lipogenesis and triglyceride storage.肝脏蛋白质组学揭示了与从头脂肪生成相关的蛋白质和甘油三酯储存之间的脱节。
J Lipid Res. 2024 Dec;65(12):100687. doi: 10.1016/j.jlr.2024.100687. Epub 2024 Oct 25.
10
A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones.一种利用丙酮酸、乙酸盐和酮的分级肝脏从头脂肪生成底物供应网络。
Cell Metab. 2025 Jan 7;37(1):255-273.e6. doi: 10.1016/j.cmet.2024.10.013. Epub 2024 Oct 28.
Trends Endocrinol Metab. 2021 Jan;32(1):7-19. doi: 10.1016/j.tem.2020.11.002. Epub 2020 Nov 23.
4
The glucose-sensing transcription factor ChREBP is targeted by proline hydroxylation.葡萄糖感应转录因子 ChREBP 是脯氨酸羟化作用的靶标。
J Biol Chem. 2020 Dec 11;295(50):17158-17168. doi: 10.1074/jbc.RA120.014402. Epub 2020 Oct 6.
5
Triose Kinase Controls the Lipogenic Potential of Fructose and Dietary Tolerance.三碳糖激酶控制果糖的脂肪生成潜力和饮食耐受性。
Cell Metab. 2020 Oct 6;32(4):605-618.e7. doi: 10.1016/j.cmet.2020.07.018. Epub 2020 Aug 19.
6
Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action.鉴定一种具有抗糖尿病作用、可口服的小分子化合物,该化合物可调节 TXNIP 的表达和胰高血糖素的作用。
Cell Metab. 2020 Sep 1;32(3):353-365.e8. doi: 10.1016/j.cmet.2020.07.002. Epub 2020 Jul 28.
7
Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity.脂肪细胞中激素敏感性脂肪酶和 ChREBP 的相互作用控制着胰岛素敏感性。
Nat Metab. 2019 Jan;1(1):133-146. doi: 10.1038/s42255-018-0007-6. Epub 2018 Dec 3.
8
FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake.成纤维细胞生长因子 21 通过作用于腹内侧下丘脑的谷氨酸能神经元抑制碳水化合物摄入。
Cell Metab. 2020 Aug 4;32(2):273-286.e6. doi: 10.1016/j.cmet.2020.06.008. Epub 2020 Jul 7.
9
Carbohydrate response element-binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy.糖应答元件结合蛋白通过 mTOR 复合物 1 调节糖尿病肾病中的脂质代谢。
J Cell Physiol. 2021 Jan;236(1):625-640. doi: 10.1002/jcp.29890. Epub 2020 Jun 24.
10
DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1.DDB1 E3 连接酶通过 CRY1 控制饮食果糖诱导的 ChREBPα 稳定和肝脂肪变性。
Metabolism. 2020 Jun;107:154222. doi: 10.1016/j.metabol.2020.154222. Epub 2020 Apr 1.